UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 166

Sortiert nach

The efficacy and safety of amifostine for the acute radiation syndrome

Expert opinion on drug safety, 2019-11, Vol.18 (11), p.1077-1090

2019

Link zum Volltext

Verfügbarkeit prüfen

A review of radiation countermeasures focusing on injury-specific medicinals and regulatory approval status: part I. Radiation sub-syndromes, animal models and FDA-approved countermeasures

International journal of radiation biology, 2017-09, Vol.93 (9), p.851-869

2017

Link zum Volltext

Verfügbarkeit prüfen

How necessary are animal models for modern drug discovery?

Expert opinion on drug discovery, 2021-12, Vol.16 (12), p.1391-1397

2021

Link zum Volltext

Verfügbarkeit prüfen

Colony-stimulating factors for the treatment of the hematopoietic component of the acute radiation syndrome (H-ARS): A review

Cytokine (Philadelphia, Pa.), 2015-01, Vol.71 (1), p.22-37

2015

Link zum Volltext

Verfügbarkeit prüfen

Repurposing Pharmaceuticals Previously Approved by Regulatory Agencies to Medically Counter Injuries Arising Either Early or Late Following Radiation Exposure

Frontiers in pharmacology, 2021-05, Vol.12

2021

Link zum Volltext

Verfügbarkeit prüfen

Vitamin E: tocopherols and tocotrienols as potential radiation countermeasures

Journal of radiation research, 2013-11, Vol.54 (6), p.973-988

2013

Link zum Volltext

Verfügbarkeit prüfen

Analysis of the metabolomic profile in serum of irradiated nonhuman primates treated with Ex-Rad, a radiation countermeasure

Scientific reports, 2021-06, Vol.11 (1), p.11449-11449, Article 11449

2021

Link zum Volltext

Verfügbarkeit prüfen

Histopathological studies of nonhuman primates exposed to supralethal doses of total- or partial-body radiation: influence of a medical countermeasure, gamma-tocotrienol

Scientific reports, 2024-03, Vol.14 (1), p.5757-5757

2024

Link zum Volltext

Verfügbarkeit prüfen

Progenitors mobilized by gamma-tocotrienol as an effective radiation countermeasure

PloS one, 2014-11, Vol.9 (11), p.e114078-e114078

2014

Link zum Volltext

Verfügbarkeit prüfen

Radiation countermeasures for hematopoietic acute radiation syndrome: growth factors, cytokines and beyond

International journal of radiation biology, 2021-11, Vol.97 (11), p.1526-1547

2021

Link zum Volltext

Verfügbarkeit prüfen

Pharmacological management of ionizing radiation injuries: current and prospective agents and targeted organ systems

Expert opinion on pharmacotherapy, 2020-02, Vol.21 (3), p.317-337

2020

Link zum Volltext

Verfügbarkeit prüfen

Entolimod as a radiation countermeasure for acute radiation syndrome

Drug discovery today, 2021-01, Vol.26 (1), p.17-30

2021

Link zum Volltext

Verfügbarkeit prüfen

BIO 300: a promising radiation countermeasure under advanced development for acute radiation syndrome and the delayed effects of acute radiation exposure

Expert opinion on investigational drugs, 2020-05, Vol.29 (5), p.429-441

2020

Link zum Volltext

Verfügbarkeit prüfen

A review of radiation countermeasures focusing on injury-specific medicinals and regulatory approval status: part II. Countermeasures for limited indications, internalized radionuclides, emesis, late effects, and agents demonstrating efficacy in large animals with or without FDA IND status

International journal of radiation biology, 2017-09, Vol.93 (9), p.870-884

2017

Link zum Volltext

Verfügbarkeit prüfen

Alterations in Tissue Metabolite Profiles with Amifostine-Prophylaxed Mice Exposed to Gamma Radiation

Metabolites, 2020-05, Vol.10 (5), p.211

2020

Link zum Volltext

Verfügbarkeit prüfen

The potential value of 5-androstenediol in countering acute radiation syndrome

Drug discovery today, 2024-02, Vol.29 (2), p.103856-103856, Article 103856

2024

Link zum Volltext

Verfügbarkeit prüfen

Development of gamma-tocotrienol as a radiation medical countermeasure for the acute radiation syndrome: current status and future perspectives

Expert opinion on investigational drugs, 2023-01, Vol.32 (1), p.25-35

2023

Link zum Volltext

Verfügbarkeit prüfen

An interlaboratory comparison of dosimetry for a multi-institutional radiobiological research project: Observations, problems, solutions and lessons learned

International journal of radiation biology, 2016-02, Vol.92 (2), p.59-70

2016

Link zum Volltext

Verfügbarkeit prüfen

Radiation protectants: current status and future prospects

Health physics (1958), 2005-11, Vol.89 (5), p.531

Seed, Thomas M

2005

Link zum Volltext

Verfügbarkeit prüfen

Amelioration of radiation-induced hematopoietic and gastrointestinal damage by Ex-RAD(R) in mice

Journal of radiation research, 2012-07, Vol.53 (4), p.526-536

2012

Link zum Volltext

Verfügbarkeit prüfen

Protein biomarkers for radiation injury and testing of medical countermeasure efficacy: promises, pitfalls, and future directions

Expert review of proteomics, 2023-10, Vol.20 (10), p.221-246

2023

Link zum Volltext

Verfügbarkeit prüfen

The safety and efficacy of interleukin 11 for radiation injury

Expert opinion on drug safety, 2023-02, Vol.22 (2), p.105-109

2023

Link zum Volltext

Verfügbarkeit prüfen

Metabolomics-based predictive biomarkers of radiation injury and countermeasure efficacy: current status and future perspectives

Expert review of molecular diagnostics, 2021-07, Vol.21 (7), p.641-654

2021

Link zum Volltext

Verfügbarkeit prüfen

A review of radiation countermeasures focusing on injury-specific medicinals and regulatory approval status: part III. Countermeasures under early stages of development along with 'standard of care' medicinal and procedures not requiring regulatory approval for use

International journal of radiation biology, 2017-09, Vol.93 (9), p.885-906

2017

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 166

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(160)
Mit Volltextzugriff
(131)

Publikationsform

Sprache

Englisch
(166)
Japanisch
(30)

Erscheinungsjahr

n.n

Thema

Science & Technology
(112)
Life Sciences & Biomedicine
(100)
Animals
(77)
Humans
(64)
Mice
(41)
Male
(40)
Female
(33)
Radiation-Protective Agents - Pharmacology
(25)
Radiation
(23)
Biological And Medical Sciences
(22)
Pharmacology & Pharmacy
(21)
Radiology, Nuclear Medicine & Medical Imaging
(19)
Biology
(17)
Medical Sciences
(17)
Adult
(16)
Life Sciences & Biomedicine - Other Topics
(16)
Radiation Injuries - Prevention & Control
(15)
United States
(15)
Animal Models
(14)
Radiation-Protective Agents - Therapeutic Use
(13)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

The efficacy and safety of amifostine for the acute radiation syndrome

A review of radiation countermeasures focusing on injury-specific medicinals and regulatory approval status: part I. Radiation sub-syndromes, animal models and FDA-approved countermeasures

How necessary are animal models for modern drug discovery?

Colony-stimulating factors for the treatment of the hematopoietic component of the acute radiation syndrome (H-ARS): A review

Repurposing Pharmaceuticals Previously Approved by Regulatory Agencies to Medically Counter Injuries Arising Either Early or Late Following Radiation Exposure

Vitamin E: tocopherols and tocotrienols as potential radiation countermeasures

Analysis of the metabolomic profile in serum of irradiated nonhuman primates treated with Ex-Rad, a radiation countermeasure

Histopathological studies of nonhuman primates exposed to supralethal doses of total- or partial-body radiation: influence of a medical countermeasure, gamma-tocotrienol

Progenitors mobilized by gamma-tocotrienol as an effective radiation countermeasure

Radiation countermeasures for hematopoietic acute radiation syndrome: growth factors, cytokines and beyond

Pharmacological management of ionizing radiation injuries: current and prospective agents and targeted organ systems

Entolimod as a radiation countermeasure for acute radiation syndrome

BIO 300: a promising radiation countermeasure under advanced development for acute radiation syndrome and the delayed effects of acute radiation exposure

A review of radiation countermeasures focusing on injury-specific medicinals and regulatory approval status: part II. Countermeasures for limited indications, internalized radionuclides, emesis, late effects, and agents demonstrating efficacy in large animals with or without FDA IND status

Alterations in Tissue Metabolite Profiles with Amifostine-Prophylaxed Mice Exposed to Gamma Radiation

Models for Evaluating Agents Intended for the Prophylaxis, Mitigation and Treatment of Radiation Injuries Report of an NCI Workshop, December 3–4, 2003

The potential value of 5-androstenediol in countering acute radiation syndrome

Development of gamma-tocotrienol as a radiation medical countermeasure for the acute radiation syndrome: current status and future perspectives

An interlaboratory comparison of dosimetry for a multi-institutional radiobiological research project: Observations, problems, solutions and lessons learned

Radiation protectants: current status and future prospects

Amelioration of radiation-induced hematopoietic and gastrointestinal damage by Ex-RAD(R) in mice

Protein biomarkers for radiation injury and testing of medical countermeasure efficacy: promises, pitfalls, and future directions

The safety and efficacy of interleukin 11 for radiation injury

Metabolomics-based predictive biomarkers of radiation injury and countermeasure efficacy: current status and future perspectives

A review of radiation countermeasures focusing on injury-specific medicinals and regulatory approval status: part III. Countermeasures under early stages of development along with 'standard of care' medicinal and procedures not requiring regulatory approval for use

Suchergebnisse filtern